Among CD4+ T cell subsets, rapamycin-treated PBMC obtained from active GPA/MPA patients exhibited a significantly lower population of CD4+IFN-γ+ T cells than untreated PBMC obtained from the same patients, which was similar to the results of Figure 1. This evidence concerns the gene CD4 and granulomatosis with polyangiitis.